Xiaogang Weng

2.3k total citations
99 papers, 1.7k citations indexed

About

Xiaogang Weng is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Xiaogang Weng has authored 99 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Pharmacology and 20 papers in Complementary and alternative medicine. Recurrent topics in Xiaogang Weng's work include Traditional Chinese Medicine Analysis (13 papers), Pharmacological Effects of Natural Compounds (11 papers) and Plant-based Medicinal Research (9 papers). Xiaogang Weng is often cited by papers focused on Traditional Chinese Medicine Analysis (13 papers), Pharmacological Effects of Natural Compounds (11 papers) and Plant-based Medicinal Research (9 papers). Xiaogang Weng collaborates with scholars based in China, Denmark and Sweden. Xiaogang Weng's co-authors include Liu Z, Xiaoxin Zhu, Jesper Gromada, Sebastian Barg, Patrik Rorsman, Weiyan Cai, Takahiro Kanno, Sven Göpel, Qi Li and Zhiwei Feng and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaogang Weng

96 papers receiving 1.6k citations

Peers

Xiaogang Weng

SURGE

EPIDE

PHARM

PHEOH

Yeji Kim South Korea

Isabel Ballester Spain

Haiqing Shen China

In‐Ah Lee South Korea

Tatsuya Moriyama Japan

Shu Jiang China

Mohamed M. Hafez Egypt

Marı́a Isabel Torres Spain

Eun‐Ha Joh South Korea

Mahbubeh Setorki Iran

Yeji Kim South Korea

Xiaogang Weng

1.4k ×1.7

232 ×0.9

SURGE

287 ×1.2

EPIDE

100 ×0.5

PHARM

105 ×0.6

PHEOH

Citations per year, relative to Xiaogang Weng Xiaogang Weng (= 1×) peers Yeji Kim

Countries citing papers authored by Xiaogang Weng

Since Specialization

Citations

This map shows the geographic impact of Xiaogang Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Weng more than expected).

Fields of papers citing papers by Xiaogang Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaogang Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Weng. The network helps show where Xiaogang Weng may publish in the future.

Co-authorship network of co-authors of Xiaogang Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Weng. A scholar is included among the top collaborators of Xiaogang Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Weng. Xiaogang Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yanli, Jieyuan Liu, Yuhan Dong, et al.. (2024). A comprehensive review on pharmacokinetic mechanism of herb-herb/drug interactions in Chinese herbal formula. Pharmacology & Therapeutics. 264. 108728–108728. 15 indexed citations

Li, Yanrong, et al.. (2023). Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Frontiers in Immunology. 14. 1052756–1052756. 48 indexed citations

Zhang, Yuting, Yuchen Liu, Yan Liu, et al.. (2023). Plasma membrane lipid composition and metabolomics analysis of Yorkshire boar sperms with high and low resistance to cryopreservation. Theriogenology. 206. 28–39. 20 indexed citations

Liu, Li, Qing Yang, Xiaogang Weng, et al.. (2023). Shenlian extract protected ox-LDL-loaded macrophages against ER stress by promoting LAL-LXRα mediated cholesterol flux. Journal of Ethnopharmacology. 317. 116721–116721. 3 indexed citations

Du, Yong, et al.. (2023). Insect recognition based on complementary features from multiple views. Scientific Reports. 13(1). 2966–2966. 13 indexed citations

Song, Min Seok, Jingjing Li, Qing Yang, et al.. (2023). Shenlian extract improves atherosclerosis by relieving adventitial inflammation. Journal of Ethnopharmacology. 320. 117339–117339. 6 indexed citations

Li, Jingjing, Yajie Wang, Qing Yang, et al.. (2022). Network pharmacology analysis and experimental validation to explore the mechanism of Shenlian extract on myocardial ischemia. Journal of Ethnopharmacology. 288. 114973–114973. 16 indexed citations

Yu, Lili, et al.. (2022). The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Frontiers in Pharmacology. 13. 780496–780496. 89 indexed citations

Li, Qi, Li Liu, Qing Yang, et al.. (2021). Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment. Frontiers in Immunology. 12. 774230–774230. 5 indexed citations

10.

Li, Tongtong, Qun Li, Xia Xiao, et al.. (2020). Pig‐specific RNA editing during early embryo development revealed by genome‐wide comparisons. FEBS Open Bio. 10(7). 1389–1402. 5 indexed citations

11.

Yin, Jie, Ting Luo, Li Liu, et al.. (2020). Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells. Frontiers in Pharmacology. 11. 522729–522729. 18 indexed citations

12.

Li, Qi, Yuan Guo, Qing Yang, et al.. (2020). Extract of Caulis Spatholobi, a novel platelet inhibitor,efficiently suppresses metastasis of colorectal cancer by targeting tumor cell-induced platelet aggregation. Biomedicine & Pharmacotherapy. 123. 109718–109718. 29 indexed citations

13.

Wu, Shuang, Renyue Wei, Yan Li, et al.. (2019). The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells. Journal of Veterinary Science. 20(3). e23–e23. 12 indexed citations

14.

Qiang, Weijie, Weiyan Cai, Qing Yang, et al.. (2018). Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation. Neuroscience. 395. 1–12. 51 indexed citations

15.

Li, Qi, Ying Chen, Yujie Li, et al.. (2015). Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway. Drug Design Development and Therapy. 9. 5301–5301. 5 indexed citations

16.

Li, Yujie, Yan Guo, Qing Yang, et al.. (2015). Flavonoids casticin and chrysosplenol D from Artemisia annua L. inhibit inflammation in vitro and in vivo. Toxicology and Applied Pharmacology. 286(3). 151–158. 54 indexed citations

17.

Chen, Ying, Yuejie Li, Yajie Wang, et al.. (2014). Comparative pharmacokinetics of active alkaloids after oral administration of Rhizoma Coptidis extract and Wuji Wan formulas in rat using a UPLC–MS/MS method. European Journal of Drug Metabolism and Pharmacokinetics. 40(1). 67–74. 14 indexed citations

18.

Weng, Xiaogang. (2012). Research Progress of Endothelial Dysfunction and Atherosclerosis. Zhongguo shiyan fangjixue zazhi. 1 indexed citations

19.

Li, Xiaoqiong, Yaohong Zhu, Hongfu Zhang, et al.. (2012). Risks Associated with High-Dose Lactobacillus rhamnosus in an Escherichia coli Model of Piglet Diarrhoea: Intestinal Microbiota and Immune Imbalances. PLoS ONE. 7(7). e40666–e40666. 116 indexed citations

20.

Liu, Xiaoni, Yujie Li, Qing Yang, et al.. (2012). In vitro inhibitory and pro-apoptotic effect of Stellera Chamaejasme L Extract on human lung cancer cell line NCI-H157. Journal of Traditional Chinese Medicine. 32(3). 404–410. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact